Driving The Next Wave Of Innovation In Clinical Data Management

Clinical trials are changing. Across the industry, there is a movement towards risk-based evidence generation and decentralized trials that better accommodate patient needs. Simultaneously, clinical data volumes are increasing and diversifying with the integration of electronic health records, wearable devices, and other digital health technologies. To successfully traverse this shifting landscape, companies are activating AI-enabled trial tools to establish seamless workflows and real-time data review, protecting patients and improving speed.

At PPD , the clinical research business of Thermo Fisher Scientific, Naomi Wilson is the Vice President of Clinical Data Management, bringing 30+ years of experience across toxicology, project management, data integration, and global expansion. In a recent Q&A session, Wilson spoke to the company’s Intelligent Clinical Suite, an AI-powered technology solution designed to proactively curate data and advance clinical development. Download the full article to read Wilson’s insights into the evolving clinical space and how innovative solutions are helping companies adapt.